A cationic cholesterol based nanocarrier for the delivery of p53-EGFP-C3 plasmid to cancer cells
Authors:
- Santosh K. MisraSMSantosh K. Misra
- Sarwat NazSNSarwat Naz
- Paturu KondaiahPKPaturu Kondaiah
- Santanu BhattacharyaSBSantanu Bhattacharya
- 1 January 2014
- journal article
- Published by Elsevier in Biomaterials
- Vol. 35 (4) , 1334-1346
Abstract
No abstract availableKeywords
Funding Information
- Department of Science and Technology, Government of Rajasthan
This publication has 57 references indexed in Scilit:
- Endosomal escape and transfection efficiency of PEGylated cationic liposome–DNA complexes prepared with an acid-labile PEG-lipidBiomaterials, 2012
- Nanoparticle-Mediated Measurement of Target–Drug Binding in Cancer CellsACS Nano, 2011
- Cytoplasmic Delivery of Liposomal Contents Mediated by an Acid-Labile Cholesterol-Vinyl Ether-PEG ConjugateBioconjugate Chemistry, 2008
- Urocanic acid-modified chitosan-mediated p53 gene delivery inducing apoptosis of human hepatocellular carcinoma cell line HepG 2 is involved in its antitumor effect in vitro and in vivoBiochemical and Biophysical Research Communications, 2008
- Novel Glioblastoma Markers with Diagnostic and Prognostic Value Identified through Transcriptome AnalysisClinical Cancer Research, 2008
- Expression profiling of genes regulated by TGF-beta: Differential regulation in normal and tumour cellsBMC Genomics, 2007
- Protein kinase PKC delta and c‐Abl are required for mitochondrial apoptosis induction by genotoxic stress in the absence of p53, p73 and Fas receptorFEBS Letters, 2006
- Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic MutationsScience, 1994
- Protein kinase C inhibitors induce apoptosis in human malignant glioma cell linesFEBS Letters, 1994
- Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats.Stroke, 1993